Oncology | Emerging Role of Immunotherapy in Patients w/Triple-Negative Breast CA

Triple negative breast cancer (TNBC) is a biologically heterogeneous disease that accounts for about 15% of all breast cancers. Unlike luminal breast tumors, which express the estrogen receptor and/or progesterone receptor, and human epidermal growth factor receptor-2-overexpressing (HER-2+) breast cancers, TNBC does not express a prototypical target for therapy that has been clinically validated.


 

Additional information
Contact email: 
Course summary
Available credit: 
  • 0.50 ANCC
Course opens: 
03/12/2018
Course expires: 
03/12/2019
Cost:
$0.00
Parent activity set: 

Faculty Author
Leisha A. Emens, MD, PhD 

Associate Professor of Oncology
Johns Hopkins University School of Medicine
Bloomberg-Kimmel Institute for Cancer Immunotherapy 
Baltimore, Maryland

  • Accreditation Statement:  The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
  • Statement of Contact Hours:  This educational activity is provided by The Institute for Johns Hopkins Nursing. The  contact hours will be awarded from the Oncology Consults website after the completion.
  • Conflict of Interest:  It is the policy of The Institute for Johns Hopkins Nursing to require our continuing nursing education program faculty and planning committee members to disclose any financial relationships with companies providing program funding or manufacturers of any commercial products discussed in the program.  The planning committee and program faculty report that they do not have financial relationships with manufacturers of any commercial products they discuss in the program.
  • Commercial Support:  This educational activity has not received any form of commercial support.
  • Non-Endorsement of Products:  The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center does not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.

Available Credit

  • 0.50 ANCC

Accreditation Period

Course opens: 
03/12/2018
Course expires: 
03/12/2019

Price

Cost:
$0.00
Please login or register to take this course.

You will be redirected to the Oncology Consults website.


If you do not have an account on their website you will need to create an account before logging in to access this free course.

Click HERE to be directed to the article and proceed as instructed on the site. A certificate of participation will be available online immediately following successful completion of the activity.